C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/2002
10/24/2002	US20020156076 Imidazole derivatives used to reduce ocular pressure or treat glaucoma and other diseases
10/24/2002	US20020156054 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
10/24/2002	US20020155505 Methods for ligand discovery
10/24/2002	DE10119204A1 Production of new or known 5-aryl-1,3,3-trimethyl-2-methylene-indoline derivatives useful in compositions for dyeing keratin and other fibers, especially human hair
10/24/2002	DE10108481A1 Pyridylpyrimidine Pyridylpyrimidines
10/24/2002	CA2444596A1 Large conductance calcium-activated k channel opener
10/24/2002	CA2444264A1 Prodrugs via acylation with cinnamate
10/24/2002	CA2444148A1 Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents
10/24/2002	CA2443697A1 1,4-disubstituted benzo-fused compounds
10/24/2002	CA2441274A1 Aurones as telomerase inhibitors
10/24/2002	CA2431553A1 Cxcr3 antagonists
10/23/2002	EP1251127A1 Novel sidechain-bearing taxanes and intermediates thereof
10/23/2002	EP1250337A1 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
10/23/2002	EP1250335A2 Process and intermediates for the preparation of imidazopyridines
10/23/2002	EP1250333A1 Dendrimer precursor dyes for imaging
10/23/2002	EP1250332A1 Inhibitors of interleukin 5 gene expression
10/23/2002	EP1250328A1 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
10/23/2002	EP1250095A1 Versatile hydrophilic dyes
10/23/2002	EP1250094A1 Tunable indocyanine dyes for biomedical applications
10/23/2002	EP1250092A1 Novel dyes
10/23/2002	EP1250047A2 Herbicidal composition
10/23/2002	EP1196384A4 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
10/23/2002	EP1162202B1 Method for obtaining polymorph a from doxazosine mesylate
10/23/2002	EP1161427B1 Improved process for asymmetric hydrogenation
10/23/2002	EP1086095B1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
10/23/2002	EP1073642B1 The use of dihydropyrimidines as medicaments, and novel substances for the treatment of hepatitis b
10/23/2002	EP0894089B1 Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
10/23/2002	EP0869947B1 Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
10/23/2002	EP0783499B1 Benzofuran derivatives as tachykinin antagonists
10/23/2002	EP0674630B1 7-HALO- AND 7$g(b),8$g(b)-METHANO-TAXOLS, ANTINEOPLASTIC USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
10/23/2002	CN1376155A Thiourea and isothiourea derivatives for inhibiting RAS-transformed cell growth
10/23/2002	CN1376154A Piperidine derivatives as serotonine reuptake inhibitors
10/23/2002	CN1376149A 2,4-diamino-1,3,5-triazine, method for the production and use of the same as herbicides and plant growth regulators
10/23/2002	CN1376148A Rate-controlled particles
10/23/2002	CN1376147A 吡唑类衍生物 Pyrazole derivatives
10/23/2002	CN1093127C 哌嗪衍生物 Piperazine derivatives
10/23/2002	CN1093124C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to PPAR-gamma
10/23/2002	CA2381630A1 Method for preventing dyskinesias
10/22/2002	US6469196 Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides
10/22/2002	US6469162 Compounds with chelation affinity and selectivity for first transition series elements: use in medical therapy and diagnosis
10/22/2002	US6469065 Compound that donates, transfers or releases nitric oxide, elevates endogenous levels of nitric oxide
10/22/2002	US6469045 Thalidomide and various related compounds such as thalidomide precursors, analogs, metabolites and hydrolysis products; oral administration
10/22/2002	US6469032 3-(4′-bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease
10/22/2002	US6469031 Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists
10/22/2002	US6469028 Synthesis and use of retinoid compounds having negative hormone and/or anatgonist activities
10/22/2002	US6469024 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
10/22/2002	US6469010 Medicament for the alleviation or treatment of symptom derived from the ischemic disease and compound useful thereof
10/22/2002	US6469007 P-substituted-n-(2-(4-(2,3-dihydro-benzo(1,4)dioxin-5-yl) -piperazin-1-yl)-propyl)-n-pyridin-2-yl-benzamide,
10/22/2002	US6469006 Particularly for treating hiv infections
10/22/2002	US6469003 Pyridazinone derivatives
10/22/2002	US6469002 Compounds which modulate chemokine receptor activity and are useful in treatment of inflammatory diseases
10/22/2002	US6468958 Light, oxygen and heat resistance
10/22/2002	US6468741 Electrochemiluminescent rhenium moieties
10/17/2002	WO2002081491A2 New genistein derivatives and pharmaceutical preparations containing them
10/17/2002	WO2002081463A1 Antagonists of mcp-1 function and methods of use thereof
10/17/2002	WO2002081460A1 Lipid lowering biphenylcarboxamides
10/17/2002	WO2002081453A1 Thiohydantoins and use thereof for treating diabetes
10/17/2002	WO2002081449A1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
10/17/2002	WO2002081432A2 Sulfoxides or sulfones grafted onto polymers
10/17/2002	WO2002080928A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
10/17/2002	WO2002080846A2 Epothilone derivatives and methods for making and using the same
10/17/2002	WO2002059114A9 Lfa-1 antagonist compounds
10/17/2002	WO2002044156A3 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
10/17/2002	WO2002032860A3 Dynamic organ function monitoring agents
10/17/2002	WO2001096283A9 Hiv integrase inhibitors
10/17/2002	US20020151731 Such as bis-1,2-(2-(2,3-epoxypropyl)phenoxy)ethane; chemical intermediates for formation of epoxy resins
10/17/2002	US20020151718 Synthesis of pyrrole amides
10/17/2002	US20020151716 Hydrolyzing paroxetine phenylcarbamate compound in alcohol/ hydrocarbon solvent (butanol and toluene)
10/17/2002	US20020151715 Imidazole derivatives
10/17/2002	US20020151574 Extracellular signal regulated kinase (ERK); anticancer agents and protein kinase inhibitors
10/17/2002	US20020151571 Activity against arthropods in agriculture and parasites encountered in animal husbandry
10/17/2002	US20020151567 Preparation of N-methylparoxetine and related intermediate compounds
10/17/2002	US20020151566 Phosphodiesterase 4 inhibitors
10/17/2002	US20020151565 Use of dual H3/M2 antagonists in the treatment of cognition deficit disorders
10/17/2002	US20020151555 Pyrimidine matrix metalloproteinase inhibitors
10/17/2002	US20020151553 Such as 4-(4-chlorophenyl)1-(3-(5-cyano-5H-dibenzo(a,d) cycloheptene-5-yl)propyl)piperidin-4-ol for treatment of diseases associated with aberrant leukocyte recruitment and/or activation
10/17/2002	US20020151552 Novel compounds
10/17/2002	US20020151504 Amino acid containing compounds useful as modulators of the immune system
10/17/2002	US20020151493 Therapeutic agents and methods of use thereof for the modulation of angiogenesis
10/17/2002	US20020150947 Detecting preferential biopolymer in sample; obtain sample, incubate with ligand, allow complex to form, detect complex
10/17/2002	CA2444024A1 Thiohydantoins and use thereof for treating diabetes
10/17/2002	CA2443108A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
10/17/2002	CA2442776A1 Antagonists of mcp-1 function and methods of use thereof
10/16/2002	EP1248785A1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
10/16/2002	EP1248779A2 Glycosidase ihhibitors and preparation thereof
10/16/2002	EP1248777A2 Tricyclic compounds with antiviral activity
10/16/2002	EP1248774A2 Polyhydroxystilbenes and stilbene oxides as antipsoriatic agents and protein kinase inhibitors
10/16/2002	EP1248771A1 Method for preparing hydroxypicolinic acid derivatives
10/16/2002	EP1248619A1 Amorphous paroxetine compositon
10/16/2002	EP0927161B1 Substituted cyclic amine metalloprotease inhibitors
10/16/2002	EP0641203B1 Pharmaceutical compositions of an imidazolyl-akenoic acid salt and their use as angiotensin ii antagonists
10/16/2002	EP0542136B1 1-[(1,4-benzodioxanyl)alkyl]-4-(heteroaryl) piperidines, piperazines and pyrrolidines as antipsychotic agents
10/16/2002	CN1374957A Benzopyran derivative
10/16/2002	CN1374954A New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents cnotaining these compounds
10/16/2002	CN1374952A Benzimidazolone derivatives and their use as phosphodiesterase inhibibors
10/16/2002	CN1374950A Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
10/16/2002	CN1374949A 毒蕈碱拮抗剂 Muscarinic antagonist
10/16/2002	CN1374307A Luminescent aromatic tetrahydric dianhydride containing naphthalene structure and its prepn
10/16/2002	CN1374082A Use of glycogen sulphofoenzyme inhibitor
10/16/2002	CN1092655C 哌啶衍生物 Piperidine derivatives

1 ... 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 ... 694